Bio

Expert Biotherapies 20 years of experience in biotherapies Participation in the development of Zynteglo gene therapy from preclinical studies to marketing authorization • Gene and cell therapies, viral vectors, gene editing, stem cells, rare diseases, in vitro and in vivo models, genetic diseases, hemoglobinopathies, molecular and cell biology, CAR-T cells, antibodies, recombinant proteins • International manager with experience leading R&D groups, alliances and collaborations in Europe and the USA • Program team member, cross-functional organization and strategy • Leader of multidisciplinary, collaborative, international research projects • Cure Sickle Cell Initiative (NIH/NHLBI): expert gene therapy, gene editing, sickle cell assays • Contribution to clinical studies (assay development, patient follow-up, data analysis) • Preclinical research and development, IND and CTA enabling studies (β-thalassemia, sickle cell disease) • Contribution to regulatory documents: IND/CTA, briefing books, MAA/BLA • Contribution to peer review publications and international conference presentations • Radiation Safety Officer • Biosafety committee ember • Board member of the French Society of Gene and Cell Therapy